Literature DB >> 21531051

Pharmacophore based virtual screening, molecular docking studies to design potent heat shock protein 90 inhibitors.

Sugunadevi Sakkiah1, Sundarapandian Thangapandian, Shalini John, Keun Woo Lee.   

Abstract

The identification of important chemical features of Heat Shock Protein 90 (HSP90) inhibitors will be helpful to discover the potent candidate to inhibit the HSP90 activity. The best hypothesis from Hip-Hop, Hypo1, one hydrogen bond donor (HBD), two hydrogen bond acceptors (HBA), and two hydrophobic (H) and structure-based hypothesis, SB_Hypo1, one HBA, one HBD and four H features, were generated using Discovery Studio and LigandScout, respectively. Test and decoy sets were used to corroborate the best hypotheses and the validated hypotheses were used to screen the chemical databases. Subsequently, the screened compounds were filtered by applying the rule of five, ADMET and molecular docking. Finally, four compounds were obtained as novel leads to inhibit the HSP90 activity.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21531051     DOI: 10.1016/j.ejmech.2011.04.018

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  15 in total

1.  Molecular modeling on structure-function analysis of human progesterone receptor modulators.

Authors:  Ria Pal; Md Ataul Islam; Tabassum Hossain; Achintya Saha
Journal:  Sci Pharm       Date:  2011-06-30

Review 2.  Oncogenic protein interfaces: small molecules, big challenges.

Authors:  Tracy L Nero; Craig J Morton; Jessica K Holien; Jerome Wielens; Michael W Parker
Journal:  Nat Rev Cancer       Date:  2014-03-13       Impact factor: 60.716

3.  Pharmacophore modeling, molecular docking, and molecular dynamics simulation approaches for identifying new lead compounds for inhibiting aldose reductase 2.

Authors:  Sugunadevi Sakkiah; Sundarapandian Thangapandian; Keun Woo Lee
Journal:  J Mol Model       Date:  2012-01-18       Impact factor: 1.810

4.  Exploration of structural and physicochemical requirements and search of virtual hits for aminopeptidase N inhibitors.

Authors:  Amit K Halder; Achintya Saha; Tarun Jha
Journal:  Mol Divers       Date:  2013-01-23       Impact factor: 2.943

5.  Structure-based pharmacophore design and virtual screening for novel potential inhibitors of epidermal growth factor receptor as an approach to breast cancer chemotherapy.

Authors:  Shabnam Mahernia; Malihe Hassanzadeh; Niusha Sharifi; Bita Mehravi; Fariba Paytam; Mehdi Adib; Massoud Amanlou
Journal:  Mol Divers       Date:  2017-12-02       Impact factor: 2.943

6.  Molecular modeling, quantum polarized ligand docking and structure-based 3D-QSAR analysis of the imidazole series as dual AT(1) and ET(A) receptor antagonists.

Authors:  Khuraijam Dhanachandra Singh; Karthikeyan Muthusamy
Journal:  Acta Pharmacol Sin       Date:  2013-12       Impact factor: 6.150

7.  Molecular docking and pharmacophore studies of heterocyclic compounds as Heat shock protein 90 (Hsp90) Inhibitors.

Authors:  Suby T Baby; Shailendra Sharma; Sreenivas Enaganti; P Roby Cherian
Journal:  Bioinformation       Date:  2016-06-15

8.  In Vitro and In Vivo Evaluation of Polyherbal Formulation against Russell's Viper and Cobra Venom and Screening of Bioactive Components by Docking Studies.

Authors:  G Sakthivel; Amitabha Dey; Kh Nongalleima; Murthy Chavali; R S Rimal Isaac; N Surjit Singh; Lokesh Deb
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-28       Impact factor: 2.629

9.  Dynamic and multi-pharmacophore modeling for designing polo-box domain inhibitors.

Authors:  Sugunadevi Sakkiah; Silvia Senese; Qianfan Yang; Keun Woo Lee; Jorge Z Torres
Journal:  PLoS One       Date:  2014-07-18       Impact factor: 3.240

10.  In silico study of subtilisin-like protease 1 (SUB1) from different Plasmodium species in complex with peptidyl-difluorostatones and characterization of potent pan-SUB1 inhibitors.

Authors:  Simone Brogi; Simone Giovani; Margherita Brindisi; Sandra Gemma; Ettore Novellino; Giuseppe Campiani; Michael J Blackman; Stefania Butini
Journal:  J Mol Graph Model       Date:  2016-01-19       Impact factor: 2.518

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.